Jerome Tamburini Selected Research

GSK621

1/2022	AMPK-PERK axis represses oxidative metabolism and enhances apoptotic priming of mitochondria in acute myeloid leukemia.
7/2016	Co-activation of AMPK and mTORC1 as a new therapeutic option for acute myeloid leukemia.
6/2015	Co-activation of AMPK and mTORC1 Induces Cytotoxicity in Acute Myeloid Leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jerome Tamburini Research Topics

Disease

20	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2023 - 06/2006
11	Neoplasms (Cancer) 01/2023 - 08/2009
4	Leukemia 01/2023 - 06/2013
3	Lymphoma (Lymphomas) 03/2018 - 11/2011
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2022 - 12/2020
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 12/2021 - 01/2019
2	Philadelphia Chromosome 12/2021 - 01/2019
1	Oncogene Addiction 01/2022
1	Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive) 01/2020
1	Pathologic Complete Response 10/2016
1	Hodgkin Disease (Hodgkin's Disease) 07/2015
1	Plasmacytoma 06/2013
1	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 06/2013
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2012
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2012
1	Residual Neoplasm 11/2011
1	Waldenstrom Macroglobulinemia (Macroglobulinemia) 12/2010
1	Carcinogenesis 12/2009
1	Plasma Cell Leukemia 10/2008

Drug/Important Bio-Agent (IBA)

6	Mechanistic Target of Rapamycin Complex 1IBA 07/2016 - 01/2008
5	TOR Serine-Threonine KinasesIBA 04/2012 - 01/2008
4	Phosphotransferases (Kinase)IBA 01/2015 - 06/2006
4	Phosphatidylinositols (Phosphatidylinositol)IBA 04/2012 - 06/2006
3	fms-Like Tyrosine Kinase 3IBA 01/2023 - 09/2015
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 08/2009
3	GSK621IBA 01/2022 - 06/2015
3	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2008 - 06/2006
2	Transcription Factors (Transcription Factor)IBA 01/2023 - 11/2010
2	AMP-Activated Protein KinasesIBA 11/2021 - 07/2016
2	Rituximab (Mabthera)FDA Link 01/2018 - 12/2010
2	Sorafenib (BAY 43-9006)FDA Link 10/2016 - 06/2013
2	MTOR InhibitorsIBA 04/2012 - 12/2009
2	Sirolimus (Rapamycin)FDA Link 04/2012 - 08/2009
2	Metformin (Glucophage)FDA LinkGeneric 07/2011 - 11/2010
1	Azacitidine (5 Azacytidine)FDA Link 10/2023
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2023
1	LipidsIBA 01/2023
1	CCAAT-Enhancer-Binding ProteinsIBA 01/2023
1	trametinibIBA 01/2022
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2022
1	eprenetapoptIBA 01/2022
1	ponatinibIBA 12/2021
1	asciminibIBA 12/2021
1	venetoclaxIBA 11/2021
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2020
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2019
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 03/2018
1	Methotrexate (Mexate)FDA LinkGeneric 01/2018
1	Temozolomide (Temodar)FDA LinkGeneric 01/2018
1	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2018
1	Etoposide (VP 16)FDA LinkGeneric 01/2018
1	Biomarkers (Surrogate Marker)IBA 11/2016
1	HomoharringtonineIBA 10/2016
1	proto-oncogene proteins pimIBA 09/2015
1	Tyrosine Kinase InhibitorsIBA 09/2015
1	bcr-abl Fusion ProteinsIBA 01/2015
1	GTP-Binding Proteins (G-Protein)IBA 01/2015
1	Protein Kinase InhibitorsIBA 11/2013
1	Cytostatic AgentsIBA 04/2012
1	Thrombopoietin ReceptorsIBA 01/2012
1	romiplostim FDA Link 01/2012
1	AICA ribonucleotide (ZMP)IBA 07/2011
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2010
1	fludarabineIBA 12/2010
1	trans-sodium crocetinate (crocetin)IBA 11/2010
1	BiguanidesIBA 11/2010
1	dactolisibIBA 11/2010
1	Eukaryotic Initiation Factor-4F (EIF4F)IBA 08/2009
1	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2008
1	Dexamethasone (Maxidex)FDA LinkGeneric 10/2008
1	Bortezomib (Velcade)FDA Link 10/2008
1	Insulin (Novolin)FDA Link 01/2008

Therapy/Procedure

10	Therapeutics 01/2022 - 10/2008
4	Drug Therapy (Chemotherapy) 12/2020 - 11/2011
2	Stem Cell Transplantation 01/2020 - 11/2011
2	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 06/2013 - 11/2011
1	Transplantation 01/2015
1	Salvage Therapy 01/2012
1	Radiotherapy 11/2011